$40.21 0.6%
BMY Stock Price vs. AI Score (Last 150 days)
Data gathered: July 15

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Bristol-Myers Squibb

The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.


Bristol-Myers Squibb
Price $40.21
Target Price Sign up
Volume 16,680,000
Market Cap $82B
Year Range $39.46 - $52.97
Dividend Yield 5.93%
PE Ratio 12.66
Revenue per Employee $1,327,522
Earnings Date July 26 '24
Industry Drug Manufacturers

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '2411.9B7.77B4.09B-11.9B-8.69B-4.400
Q4 '2311.5B7.19B4.29B1.76B4.29B1.590
Q3 '2311B6.93B4.03B1.93B4.71B2.000
Q2 '2311.2B7.22B4.01B2.07B4.44B1.750
Q1 '2311.3B6.8B4.54B2.26B5.35B2.050

Insider Transactions View All

BOERNER CHRISTOPHER S. filed to buy 82,672 shares at $49.8.
December 7 '23
BOERNER CHRISTOPHER S. filed to buy 79,384 shares at $48.9.
November 30 '23
Samuels Theodore R. II filed to buy 35,500 shares at $49.8.
November 21 '23
Powell Ann filed to sell 27,868 shares at $61.3.
August 28 '23
Plenge Robert M filed to sell 6,584 shares at $61.1.
August 7 '23

Congress Trading View All

Politician Filing Date Type Size
Rohit Khanna
Democrat
Jun 5, 24 Sell $15K - $50K
Rohit Khanna
Democrat
Jun 5, 24 Sell $15K - $50K
Thomas Tuberville
Republican
May 15, 24 Sell $1K - $15K

What is the Market Cap of Bristol-Myers Squibb?

The Market Cap of Bristol-Myers Squibb is $82B.

What is Bristol-Myers Squibb's PE Ratio?

As of today, Bristol-Myers Squibb's PE (Price to Earnings) ratio is 12.66.

How Many People Work at Bristol-Myers Squibb?

As of our latest update, Bristol-Myers Squibb employed approximately 34,300 people worldwide. However, it's important to note that Bristol-Myers Squibb's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Bristol-Myers Squibb's revenue per employee?

$1,327,522. To calculate Bristol-Myers Squibb's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

When does Bristol-Myers Squibb report earnings?

Bristol-Myers Squibb will report its next earnings on July 26 '24.

What is the current stock price of Bristol-Myers Squibb?

Currently, the price of one share of Bristol-Myers Squibb stock is $40.21.

How can I analyze the BMY stock price chart for investment decisions?

The BMY stock price chart above provides a comprehensive visual representation of Bristol-Myers Squibb's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Bristol-Myers Squibb shares. Our platform offers an up-to-date BMY stock price chart, along with technical data analysis and alternative data insights.

Does BMY offer dividends to its shareholders?

Yes, Bristol-Myers Squibb (BMY) offers dividends to its shareholders, with a dividend yield of 5.93%. This dividend yield represents Bristol-Myers Squibb's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Bristol-Myers Squibb in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of Bristol-Myers Squibb?

Some of the similar stocks of Bristol-Myers Squibb are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.